Evidence map›Paper›PMID 40514216›Full record

ArticleBMJ global health2025

Out-of-pocket expenditure and financial risks associated with treatment of chronic kidney disease in Ethiopia: a prospective cohort costing analysis.

Solomon Tessema Memirie, Mizan Habtemichael, Hamelmal G Hailegiorgis, Leja Hamza Juhar, Tsegay Berhane, Sisay Tesfaye, Workagegnehu Hailu Bilchut, Maekel Belay Woldemariam, Lina Mohammed Ahmedtaha, Ole Frithjof Norheim

Abstract read
In one paragraph

Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Solomon Tessema MemirieAddis Center for Ethics and Priority Setting, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia tess_soul@yahoo.com.ORCID http://orcid.org/0000-0003-3806-2453
Mizan HabtemichaelAddis Center for Ethics and Priority Setting, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Hamelmal G HailegiorgisDepartment of Internal Medicine, St Paul Hospital's Millennium Medical College, Addis Ababa, Ethiopia.
Leja Hamza JuharDepartment of Internal Medicine, St Paul Hospital's Millennium Medical College, Addis Ababa, Ethiopia.
Tsegay BerhaneDepartment of Internal Medicine, St Paul Hospital's Millennium Medical College, Addis Ababa, Ethiopia.
Sisay TesfayeDepartment of Internal Medicine, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia.ORCID http://orcid.org/0000-0002-7199-9187
Workagegnehu Hailu BilchutDepartment of Internal Medicine, College of Health Sciences, University of Gondar, Gondar, Ethiopia.
Maekel Belay WoldemariamDepartment of Internal Medicine, College of Medicine and Public Health, Jimma University, Jimma, Ethiopia.
Lina Mohammed AhmedtahaDepartment of Internal Medicine, St Paul Hospital's Millennium Medical College, Addis Ababa, Ethiopia.
Ole Frithjof NorheimBergen Center for Ethics and Priority Setting (BCEPS), Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn Ethiopia, most healthcare expenditures are paid out-of-pocket (OOP), while the burden of kidney disease (KD) is rapidly increasing, posing a major public health challenge in low- and middle-income countries, along with a staggering economic burden. We aimed to quantify the extent of OOP health expenditures and the magnitude of associated catastrophic and impoverishing health expenditures (CHE and IHE) for chronic KD (CKD) care in Ethiopia.

methodsWe conducted a prospective costing analysis for CKD care from the patient perspective. We collected data on OOP health expenditures (2023 US$) and household consumption expenditures from a cohort of 433 patients that were followed prospectively for 6 months. Patients were recruited from six health facilities from four constituencies in Ethiopia. We estimated the burden of OOP payments as the sum of direct medical expenditures (DMEs) and direct non-medical expenditures (DNMEs). DMEs were calculated by summing OOP payments for consultations, diagnostic workups, procedures, medications and hospital stays. DNMEs were computed by totalling OOP expenses for transportation, food and lodging. Additionally, we estimated the economic value of productivity losses incurred by patients and/or caregivers due to time spent seeking care. We used descriptive statistics to measure the extent of CHE and IHE. We ran a logistic regression model to assess the drivers of CHE.

resultsThe mean annual OOP expenditure was US$2337 (95% CI US$2014 to US$2659) and varied by type of care: US$677 (95% CI US$511 to US$825) for outpatient care, US$2759 (95% CI US$1171 to US$4347) for inpatient care and US$5312 (95% CI US$4644 to US$5919) for haemodialysis. DMEs (particularly haemodialysis) were the major drivers of cost, accounting for 76%-85% of the total OOP expenditure. Transportation expenditures were the major contributors among the DNMEs. Among those who sought outpatient, inpatient and haemodialysis care, 36%, 67% and 90% incurred CHE, respectively, at a 10% threshold of annual consumption expenditures. Among all patients, 25.6% of households were impoverished due to OOP medical expenditures, with the rate substantially higher among those requiring haemodialysis (43.4%). Facility type and the type of visit were significantly associated with the odds of incurring CHE (p<0.05), while adjusting for wealth quintile, disease stage, area of residence (urban/rural), family size, patient age and insurance membership status.

conclusionsThe household economic burden for CKD care is substantial, likely hindering access to necessary treatment and exacerbating the impoverishment, which is prevalent in Ethiopia. This would be an obstacle in achieving universal health coverage and Sustainable Development Goals in Ethiopia.

Indexed as

Cost of IllnessFinancing, PersonalHealth ExpendituresRenal Insufficiency, ChronicAdultAgedCosts and Cost AnalysisEthiopiaFemaleHumansMaleMiddle AgedProspective StudiesYoung AdultAfrica South of the Saharahealth economics

Identifiers

PMID40514216
PMCPMC12164608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.